European Commission 27 February 2023, Commission Decision of 27/02/2023 declaring a concentration to be compatible with the common market (Case No COMP/M.10997 - NB / ARDIAN / MEDIOLANUM / NEOPHARMED) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)
Also known as
European Union · · · 27-02-2023
Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË - Tel. +32 22991111 EUROPEAN COMMISSION Brussels, 27.02.2023 C(2023) 1437 final PUBLIC VERSION NB Renaissance Partners Holdings S.à r.l. 9, Rue du Laboratoire L-1911 Luxembourg Grand Duchy of Luxembourg Ardian France S.A. 20, place Vendôme 75 001 Paris France Mediolanum Farmaceutici S.p.A.
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit